Aminoverse B.V.

Enables clients to accelerate and de-risk enzyme innovation from target reaction to tailored enzyme. Founded in 2020 by a team of entrepreneurs and scientists with more than 50 years of combined experience, Aminoverse's CRO services combine enzyme wet-lab expertise with in silico design through its proprietary AI tech stack, including EnzyNAV AI for identifying the right enzyme, EnzyMAP AI for selecting the best mutations, and EnzyREC AI for recombining the best mutations.